» Articles » PMID: 35563790

Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis

Overview
Journal Cells
Publisher MDPI
Date 2022 May 14
PMID 35563790
Authors
Affiliations
Soon will be listed here.
Abstract

The Golgi apparatus is at the center of protein processing and trafficking in normal cells. Under pathological conditions, such as in cancer, aberrant Golgi dynamics alter the tumor microenvironment and the immune landscape, which enhances the invasive and metastatic potential of cancer cells. Among these changes in the Golgi in cancer include altered Golgi orientation and morphology that contribute to atypical Golgi function in protein trafficking, post-translational modification, and exocytosis. Golgi-associated gene mutations are ubiquitous across most cancers and are responsible for modifying Golgi function to become pro-metastatic. The pharmacological targeting of the Golgi or its associated genes has been difficult in the clinic; thus, studying the Golgi and its role in cancer is critical to developing novel therapeutic agents that limit cancer progression and metastasis. In this review, we aim to discuss how disrupted Golgi function in cancer cells promotes invasion and metastasis.

Citing Articles

Subcellular Organelle Targeting as a Novel Approach to Combat Tumor Metastasis.

Liu Z, Liu Y, Kang X, Li L, Xiang Y Pharmaceutics. 2025; 17(2).

PMID: 40006565 PMC: 11859411. DOI: 10.3390/pharmaceutics17020198.


A Golgi apparatus‑related subtype and risk signature predicts prognosis and evaluates immunotherapy response in gastric cancer.

Chen R, Yao Z, Jiang L, Hu J Discov Oncol. 2025; 16(1):76.

PMID: 39841334 PMC: 11754555. DOI: 10.1007/s12672-025-01827-6.


The role of Golgi complex proteins in cell division and consequences of their dysregulation.

Iannitti R, Mascanzoni F, Colanzi A, Spano D Front Cell Dev Biol. 2025; 12():1513472.

PMID: 39839669 PMC: 11747491. DOI: 10.3389/fcell.2024.1513472.


Targeting the ERK1/2 and p38 MAPK pathways attenuates Golgi tethering factor golgin-97 depletion-induced cancer progression in breast cancer.

Liu Y, Lin T, Chong K, Chen G, Kuo C, Lin Y Cell Commun Signal. 2025; 23(1):22.

PMID: 39800687 PMC: 11727508. DOI: 10.1186/s12964-024-02010-0.


Thyroid Carcinoma Glycoproteins Express Altered -Glycans with 3-O-Sulfated Galactose Residues.

Broekhuis J, Lu D, Aryal R, Matsumoto Y, Pepi L, Chaves N Biomolecules. 2025; 14(12.

PMID: 39766189 PMC: 11727208. DOI: 10.3390/biom14121482.


References
1.
Du Y, Shen J, Hsu J, Han Z, Hsu M, Yang C . Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking. Oncogene. 2013; 33(6):756-70. PMC: 3874427. DOI: 10.1038/onc.2013.1. View

2.
Lieu Z, Lock J, Hammond L, La Gruta N, Stow J, Gleeson P . A trans-Golgi network golgin is required for the regulated secretion of TNF in activated macrophages in vivo. Proc Natl Acad Sci U S A. 2008; 105(9):3351-6. PMC: 2265200. DOI: 10.1073/pnas.0800137105. View

3.
Scott K, Kabbarah O, Liang M, Ivanova E, Anagnostou V, Wu J . GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature. 2009; 459(7250):1085-90. PMC: 2753613. DOI: 10.1038/nature08109. View

4.
Conroy L, Stanback A, Young L, Clarke H, Austin G, Liu J . Analysis of N-Linked Glycans as Potential Biomarkers of Clinical Course in Human Prostate Cancer. Mol Cancer Res. 2021; 19(10):1727-1738. PMC: 8492534. DOI: 10.1158/1541-7786.MCR-20-0967. View

5.
Makhoul C, Gosavi P, Gleeson P . Golgi Dynamics: The Morphology of the Mammalian Golgi Apparatus in Health and Disease. Front Cell Dev Biol. 2019; 7:112. PMC: 6616279. DOI: 10.3389/fcell.2019.00112. View